faslodex - fulvestrant injection
(Fulvestrant)Astrazeneca Pharmaceuticals Lp
Usage: FASLODEX treats HR-positive, HER2-negative advanced or metastatic breast cancer in postmenopausal women. Used as monotherapy (treatment-naive or after endocrine therapy) or combined with ribociclib, palbociclib, or abemaciclib following disease progression on endocrine therapy.